| Literature DB >> 33431871 |
Christian Huisman1, Young A Kim2, Shin Jeon3, Bongjin Shin3, Jeonghoon Choi1, Su Jeong Lim4, Sung Min Youn4, Younjung Park3, Medha K C3, Sangsoo Kim4, Soo-Kyung Lee3, Seunghee Lee5, Jae W Lee6.
Abstract
In humans, inactivating mutations in MLL4, which encodes a histone H3-lysine 4-methyltransferase, lead to Kabuki syndrome (KS). While dwarfism is a cardinal feature of KS, the underlying etiology remains unclear. Here we report that Mll4 regulates the development of growth hormone-releasing hormone (GHRH)-producing neurons in the mouse hypothalamus. Our two Mll4 mutant mouse models exhibit dwarfism phenotype and impairment of the developmental programs for GHRH-neurons. Our ChIP-seq analysis reveals that, in the developing mouse hypothalamus, Mll4 interacts with the transcription factor Nrf1 to trigger the expression of GHRH-neuronal genes. Interestingly, the deficiency of Mll4 results in a marked reduction of histone marks of active transcription, while treatment with the histone deacetylase inhibitor AR-42 rescues the histone mark signature and restores GHRH-neuronal production in Mll4 mutant mice. Our results suggest that the developmental dysregulation of Mll4-directed epigenetic control of transcription plays a role in the development of GHRH-neurons and dwarfism phenotype in mice.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33431871 PMCID: PMC7801453 DOI: 10.1038/s41467-020-20511-7
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919